Humacyte, Inc.HUMANASDAQ
LOADING
|||
Operating Income Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year operating income growth rate
Latest
17.95%
↑ 864% above average
Average (23q)
-2.35%
Historical baseline
Range
High:17.95%
Low:-28.22%
Volatility
-1966.3%
Relatively stable
| Period | Value |
|---|---|
| Q3 2025 | 17.95% |
| Q2 2025 | -28.22% |
| Q1 2025 | 17.46% |
| Q4 2024 | 7.09% |
| Q3 2024 | -2.49% |
| Q2 2024 | -10.99% |
| Q1 2024 | -1.51% |
| Q4 2023 | -6.34% |
| Q3 2023 | 7.89% |
| Q2 2023 | -18.74% |
| Q1 2023 | -8.28% |
| Q4 2022 | 11.51% |
| Q3 2022 | -26.78% |
| Q2 2022 | 14.85% |
| Q1 2022 | -0.63% |
| Q4 2021 | -5.28% |
| Q3 2021 | -6.61% |
| Q2 2021 | 2.53% |
| Q1 2021 | -26.14% |
| Q4 2020 | 8.95% |
| Q3 2020 | -19.96% |
| Q2 2020 | 17.37% |
| Q1 2020 | 0.00% |
| Q4 2019 | 0.00% |